CVS Health Corp (NYSE:CVS) price closed higher on Tuesday, April 16, jumping 0.10% above its previous close.
A look at the daily price movement shows that the last close reads $68.96. The company’s P/E ratio in the trailing 12-month period read 10.67. Taking into account the 52-week price action we note that the stock hit a 52-week high of $83.25 and 52-week low of $64.41. The stock subtracted -10.81% on its value in the past month.
CVS Health Corp, which has a market valuation of $86.87 billion. The company stock has a Forward Dividend ratio of 2.48, while the dividend yield is 3.59%. It is understandable that investor optimism is growing ahead of the company’s current quarter results.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give CVS a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Sell.
If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 2.89. The overview shows that CVS’s price is at present -8.67% off the SMA20 and -8.63% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 27.44, with weekly volatility standing at 2.68%. The indicator jumps to 2.12% when calculated based on the past 30 days. CVS Health Corp (NYSE:CVS)’s beta value is holding at 0.54, while the average true range (ATR) indicator is currently reading 1.81.
An analysis of the CVS Health Corp (NYSE:CVS) stock in terms of its daily trading volume indicates that the 3-month average is 10.23 million.
Current records show that the company has 1.29B in outstanding shares. The insiders’ percentage holdings are 0.19% of outstanding shares while the percentage share held by institutions stands at 82.25%. But the -12.58% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
